Correlation of chlamydia pneumoniae infection and severity of accelerated graft arteriosclerosis after cardiac transplantation

Transplantation
Aruna K SubramanianPamela C Tucker

Abstract

Chlamydia pneumoniae has been associated with atherosclerosis, although its role in the process is not clearly defined. Heart transplant recipients are known to have high titers of antibodies to C. pneumoniae, and the organism has been recovered from the coronary arteries of both transplant recipients and donors. This study evaluated association between C. pneumoniae infection and accelerated graft arteriosclerosis (AGA), also known as cardiac allograft vasculopathy (CAV), after cardiac transplantation. A case-control study was performed with 54 heart transplant recipients at the Johns Hopkins Hospital. Severe cases had >50% luminal narrowing on cardiac catheterization, mild cases <50% narrowing, and controls were free of arteriosclerotic disease. Blood specimens were examined for C. pneumoniae serology and DNA detection by polymerase chain reaction (PCR) assays. For every twofold increase in geometric mean C. pneumoniae immunoglobulin (Ig)G titer, the odds ratio for severe AGA versus controls was 3.13 (P=0.03) and for mild AGA versus control patients was 1.61 (P=0.45). On Kaplan-Meier survival analysis there was a nonsignificant trend toward faster development of CAV in patients with higher C. pneumoniae antibody titers. Overa...Continue Reading

References

Aug 1, 1979·Journal of Clinical Microbiology·S P WangJ T Grayston
Jun 23, 1989·JAMA : the Journal of the American Medical Association·M T GrattanN E Shumway
Apr 1, 1993·Journal of Clinical Pathology·C Y Tong, M Sillis
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·C ShiE Haber
Jul 1, 1997·The Journal of Infectious Diseases·L A JacksonJ T Grayston
Oct 10, 1997·Circulation·M Weis, W von Scheidt
Mar 14, 1998·The Journal of Infectious Diseases·M V Kalayoglu, G I Byrne
May 21, 1998·The Journal of Infectious Diseases·T C MoazedL A Campbell
Jun 27, 1998·Lancet·D Taylor-RobinsonM H Yacoub
Jan 14, 1999·The New England Journal of Medicine·R Ross
Oct 28, 1999·American Heart Journal·T C Quinn, C A Gaydos
Feb 24, 2001·Current Opinion in Cardiology·D BehrendtJ C Fang

❮ Previous
Next ❯

Citations

Oct 22, 2004·Current Treatment Options in Cardiovascular Medicine·Michael A Mathier, Dennis M McNamara
Nov 6, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Matthew J WeissJames S Allan
Feb 14, 2006·Current Opinion in Cardiology·Malek Kass, Haissam Haddad
Dec 9, 2008·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·James E FildesNizar Yonan
Oct 17, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·C Martin-GandulO Manuel
Oct 14, 2006·Circulation Research·Maziar RahmaniBruce M McManus

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Basal Ganglia Cerebrovascular Disease

Basal ganglia cerebrovascular disease is a condition where the blood vessels in the basal ganglia are damaged or malfunction. Discover the latest research on basal ganglia cerebrovascular disease here.